GHK-Cu (Copper Peptide)

GHK-Cu in the Published Literature

UKPWritten & reviewed by William Heath · Editor, UK Peptides research library2 min readLast reviewed 2026-08-234 cited sources

The short answer

The literature reports effects on extracellular matrix biosynthesis, antioxidant activity through copper delivery to superoxide dismutase, wound-repair models and broad gene-expression modulation. It is predominantly in vitro and animal work, with a notable concentration of authorship.

Key facts

Main reported areas
Matrix biosynthesis, antioxidant, gene expression
Evidence type
Predominantly in vitro and animal
Mechanism established
Copper binding: not in doubt
Mechanism proposed
Copper delivery to cuproenzymes
Receptor
None characterised
Authorship
Concentrated in one long programme

What is solidly established

That GHK binds copper(II) with high affinity through a defined ATCUN-type site, forming a discrete complex with its own CAS registration and characteristic blue colour. This is straightforward coordination chemistry, independently verifiable, and nothing in the literature disputes it.

What is well supported

That the complex affects matrix biosynthesis in cell culture, and that copper delivery to lysyl oxidase and superoxide dismutase is a coherent mechanism for a meaningful portion of that. The chemistry and the enzyme dependencies are independently known, which makes this more than an isolated observation.

Research material referenced

GHK-Cu 100mg, third-party HPLC tested

Buy GHK-Cu · £34.99

What is reported but weakly grounded

Broad gene-expression modulation, real as a measurement, but from Connectivity Map analysis of cultured cell lines, and several steps upstream of function. Interactions with growth-factor signalling, which lack a defined mechanism. And the anti-ageing framing, which rests on an age-decline correlation rather than on intervention evidence.

What is absent

A characterised receptor. Substantial human clinical data. Independent replication of the broader claims by unconnected groups. None of these absences refutes anything; together they define how far the evidence currently reaches.

How the evidence compares

GHK-Cu is better grounded than DSIP, which has no gene, no receptor and an unresolved central claim. It is less well grounded than the incretins, which have large randomised trials with hard endpoints. It sits where most research peptides sit: real chemistry, plausible mechanism, model-system evidence, and a gap before anything can be said about people.

How to search it

PubMed indexes the field under GHK-Cu and under glycyl-histidyl-lysine; prezatide and copper tripeptide-1 surface further records. Checking the model system and the author list on any given paper is the fastest way to establish what kind of evidence it offers and how independent it is.

Frequently asked questions

What is definitely true about GHK-Cu?

That it binds copper(II) with high affinity through a defined site, forming a discrete blue complex. That chemistry is not in dispute.

Is there human clinical evidence?

Limited. The literature is predominantly in vitro and animal work.

How does the evidence compare to other research peptides?

Better grounded than DSIP, which has no receptor and an unresolved central claim; far less than the incretins with their large randomised trials.

Continue researching

Peer-reviewed guides, comparators and matched reference materials.

Primary sources & clinical trials

Peer-reviewed research and registered trials from PubMed, ClinicalTrials.gov, PubChem, FDA and NIH. All links open in a new tab and point to the primary source, so every claim can be verified at origin.

Browse the wider literature

Live database searches, not fixed citations. Results change as new work is indexed.

UKP

Written and reviewed by

William Heath · Editor, UK Peptides research library

William Heath edits the UK Peptides research library. He is responsible for what is published here: every article is sourced to primary literature, every purity or identity statement traces to a signed third-party certificate for a specific lot, and corrections are made in place with the review date updated. No scientific or medical credentials are claimed on this site; the evidence is carried by the cited sources and the certificates, not by the byline.

More GHK-Cu (Copper Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.